Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomotaka Kawayama

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Journal of Clinical Medicine|November 26, 2022
LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline RecommendationsMarc Miravitlles, Tomotaka Kawayama, Michael Dreher
Internal Medicine (Tokyo, Japan)|April 2, 2009
High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonaleYuzuru Inoue, Tomotaka Kawayama, Tomoaki Iwanaga, et al.
Respirology (Carlton, Vic.)|January 8, 2004
Chronic eosinophilic pneumonia associated with Schizophyllum communeTomotaka Kawayama, Rei Fujiki, Toru Rikimaru, et al.
The Japanese Journal of Antibiotics|March 11, 2004
[Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia]Rei Fujiki, Toru Rikimaru, Hisamichi Aizawa, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|April 27, 2002
[A three-year review of acute respiratory tract infections caused by Streptococcus milleri group]Rei Fujiki, Tomotaka Kawayama, Toru Rikimaru, et al.
Respiratory Investigation|September 23, 2023
Management goals and stable phase management of patients with chronic obstructive pulmonary disease in the Japanese respiratory society guideline for the management of chronic obstructive pulmonary disease 2022 (6th edition)Yoko Shibata, Tomotaka Kawayama, Shigeo Muro, et al.
Respirology (Carlton, Vic.)|November 8, 2002
Fatal idiopathic acute eosinophilic pneumonia with acute lung injuryTomotaka Kawayama, Rei Fujiki, Yosuke Morimitsu, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 27, 2007
The risk factors for mortality of community-acquired pneumonia in JapanRei Fujiki, Tomotaka Kawayama, Toshihiko Ueyama, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 2, 2019
The significance of CD163-expressing macrophages in asthmaYoshihisa Tokunaga, Haruki Imaoka, Yoichiro Kaku, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|November 1, 2006
[A case of thoracic empyema with gas formation associated with Streptococcus dysgalactiae subsp. equisimilis]Keiko Ueno, Tomotaka Kawayama, Nobutaka Edakuni, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Journal of Clinical Medicine|November 26, 2022
LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline RecommendationsMarc Miravitlles, Tomotaka Kawayama, Michael Dreher
Internal Medicine (Tokyo, Japan)|April 2, 2009
High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonaleYuzuru Inoue, Tomotaka Kawayama, Tomoaki Iwanaga, et al.
Respirology (Carlton, Vic.)|January 8, 2004
Chronic eosinophilic pneumonia associated with Schizophyllum communeTomotaka Kawayama, Rei Fujiki, Toru Rikimaru, et al.
The Japanese Journal of Antibiotics|March 11, 2004
[Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia]Rei Fujiki, Toru Rikimaru, Hisamichi Aizawa, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|April 27, 2002
[A three-year review of acute respiratory tract infections caused by Streptococcus milleri group]Rei Fujiki, Tomotaka Kawayama, Toru Rikimaru, et al.
Respiratory Investigation|September 23, 2023
Management goals and stable phase management of patients with chronic obstructive pulmonary disease in the Japanese respiratory society guideline for the management of chronic obstructive pulmonary disease 2022 (6th edition)Yoko Shibata, Tomotaka Kawayama, Shigeo Muro, et al.
Respirology (Carlton, Vic.)|November 8, 2002
Fatal idiopathic acute eosinophilic pneumonia with acute lung injuryTomotaka Kawayama, Rei Fujiki, Yosuke Morimitsu, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 27, 2007
The risk factors for mortality of community-acquired pneumonia in JapanRei Fujiki, Tomotaka Kawayama, Toshihiko Ueyama, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 2, 2019
The significance of CD163-expressing macrophages in asthmaYoshihisa Tokunaga, Haruki Imaoka, Yoichiro Kaku, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|November 1, 2006
[A case of thoracic empyema with gas formation associated with Streptococcus dysgalactiae subsp. equisimilis]Keiko Ueno, Tomotaka Kawayama, Nobutaka Edakuni, et al.
Pageof 11